We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
-12.97%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$135B
AUM Growth
-$18.4B
Cap. Flow
+$4.13B
Cap. Flow %
3.07%
Top 10 Hldgs %
16.65%
Holding
3,227
New
89
Increased
1,675
Reduced
991
Closed
131

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$467M
2
CCI icon
Crown Castle
CCI
+$343M
3
C icon
Citigroup
C
+$238M
4
SBUX icon
Starbucks
SBUX
+$231M
5
IT icon
Gartner
IT
+$219M

Sector Composition

Rank Sector Weight
1 Technology 16.11%
2 Healthcare 15.25%
3 Financials 15.1%
4 Consumer Discretionary 11.4%
5 Industrials 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTSO icon
3001
Cytosorbents Corp
CTSO
$22M
$90K ﹤0.01%
+11,100
New +$110K
ENZ
3002
DELISTED
Enzo Biochem, Inc.
ENZ
$90K ﹤0.01%
32,300
CPRX
3003
DELISTED
Catalyst Pharmaceutical
CPRX
$89K ﹤0.01%
46,500
+10,100
+28% +$28.9K
TIPT icon
3004
Tiptree Inc
TIPT
$655M
$89K ﹤0.01%
15,900
CMBT
3005
CMB.TECH NV
CMBT
$4.65B
$89K ﹤0.01%
12,771
TYME
3006
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$88K ﹤0.01%
23,800
+13,700
+136% +$38.5K
TTSH
3007
DELISTED
Tile Shop Holdings
TTSH
$87K ﹤0.01%
15,930
-7,600
-32% -$46.5K
AXTI icon
3008
AXT Inc
AXTI
$3.07B
$85K ﹤0.01%
19,600
+4,800
+32% +$26.6K
CNTY icon
3009
Century Casinos
CNTY
$33.2M
$81K ﹤0.01%
10,900
-2,800
-20% -$19.1K
MRNS
3010
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$81K ﹤0.01%
7,050
BNED icon
3011
Barnes & Noble Education
BNED
$430M
$80K ﹤0.01%
200
-46
-19% -$25.6K
LUMO
3012
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$79K ﹤0.01%
5,800
KDMN
3013
DELISTED
Kadmon Holdings, Inc.
KDMN
$79K ﹤0.01%
38,000
+9,500
+33% +$23.9K
EGAN icon
3014
eGain
EGAN
$183M
$74K ﹤0.01%
+11,200
New +$81.4K
RAIL icon
3015
FreightCar America
RAIL
$261M
$74K ﹤0.01%
11,000
-1,000
-8% -$11.3K
LQDT icon
3016
Liquidity Services
LQDT
$1.19B
$73K ﹤0.01%
11,900
-600
-5% -$3.71K
NCSM icon
3017
NCS Multistage Holdings
NCSM
$119M
$73K ﹤0.01%
715
+130
+22% +$25K
TAC icon
3018
TransAlta
TAC
$4.06B
$73K ﹤0.01%
17,600
AGI icon
3019
Alamos Gold
AGI
$11.9B
$72K ﹤0.01%
19,924
BVH
3020
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$72K ﹤0.01%
+2,500
New +$77K
ELGX
3021
DELISTED
Endologix Inc
ELGX
$72K ﹤0.01%
10,046
-1,260
-11% -$14K
ICD
3022
DELISTED
Independence Contract Drilling, Inc.
ICD
$71K ﹤0.01%
1,130
+70
+7% +$5.26K
ELVT
3023
DELISTED
Elevate Credit, Inc.
ELVT
$71K ﹤0.01%
15,800
+3,300
+26% +$17.3K
UUUU icon
3024
Energy Fuels
UUUU
$2.93B
$70K ﹤0.01%
24,700
+13,300
+117% +$43K
SYRS
3025
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$70K ﹤0.01%
1,250

Similar funds

AllianceBernstein's Q4 2018 Portfolio in Review

As of Q4 2018, AllianceBernstein held 3,227 positions worth $135B, down 12% from $153B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

AllianceBernstein deployed $4.13B of net new capital in Q4 2018, opening 89 new positions and adding to 1,675 existing holdings. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 5,205,127 shares worth $435M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Crown Castle, an estimated $343M trimmed.

  • AllianceBernstein's largest Q4 2018 buy was iShares 1-3 Year Treasury Bond ETF: 5,205,127 shares worth $435M.
  • AllianceBernstein added most to Microsoft in Q4 2018, an estimated $667M increase.
  • AllianceBernstein's biggest Q4 2018 reduction was Crown Castle, cutting an estimated $343M.
  • AllianceBernstein fully exited Aetna Inc in Q4 2018, selling an estimated $467M.
  • AllianceBernstein's ten largest holdings make up 17% of its $135B portfolio in Q4 2018.
  • AllianceBernstein opened 89 new positions and closed 131 in Q4 2018.
  • AllianceBernstein's portfolio value fell 12% quarter-over-quarter to $135B.

Based on AllianceBernstein's 13F filing for Q4 2018, filed 13 Feb 2019.